Hosted on MSN

Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Johnson & Johnson is one of them. Johnson & Johnson (NYSE:JNJ), a global healthcare leader, ...

Johnson & Johnson Wins FDA Nod For First Precision Combo For Mutated Prostate Cancer

FDA approves Johnson & Johnson's Akeega combo for BRCA2 metastatic prostate cancer after Phase 3 data showed major reductions in progression risk.
MassDevice

Medtronic, J&J MedTech both get FDA nods for liquid embolic systems

Earlier this month, Medtronic said the FDA granted the indication for its Onyx liquid embolic system (LES) in the U.S. Onyx ...

Johnson & Johnson (JNJ) Ends Mid-Stage Eczema Study After Missing Efficacy Bar

On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...
Seeking Alpha

FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder

TITUSVILLE, N.J., Nov. 6, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved CAPLYTA ® (lumateperone) as an adjunctive therapy ...
Stocktwits on MSN

Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
KFGO

Johnson & Johnson halts mid-stage trial of experimental eczema drug

Johnson & Johnson said on Friday it discontinued a mid-stage study of its ‍experimental drug to treat patients with moderate ...
Benzinga.com

FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression

The U.S. Food and Drug Administration (FDA) approved on Thursday Johnson & Johnson’s (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a type of blood cancer. Darzalex Faspro is the ...
CURE

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), the first and only subcutaneous therapy for patients with epidermal growth ...
NJBIZ

FDA approves J&J’s Caplyta as add-on depression drug

The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson‘s Caplyta as an add-on treatment for adults with major depressive disorder. Following the FDA’s Nov. 5 decision ...
Becker's Hospital Review

Johnson & Johnson and FDA Clash Over Rejection of Sedative

Johnson & Johnson has clashed with the Food and Drug Administration following the FDA’s rejection of a sedative containing the drug propofol, according to a Wall Street Journal report. The device, ...
fox6now

Johnson & Johnson seeks FDA approval of COVID-19 booster shot

NEW BRUNSWICK, N.J. - Johnson & Johnson said Tuesday it has asked the U.S. Food and Drug Administration to authorize a booster shot for its single-dose COVID-19 vaccine as the government looks to ...